MiMedx Group Stock Price. Everything You Need To Know About The MiMedx Group Stock!
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 867 full-time employees. The company went IPO on 2007-08-20. The firm is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. The firm is focused on addressing unmet clinical needs in the areas of Advanced Wound Care, Surgical Recovery, and osteoarthritis. The firm operates through two segments: Wound and Surgical, and Regenerative Medicine. The Wound and Surgical segment focuses on the Advanced Wound Care and Surgical Recovery markets. Its platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc. The Regenerative Medicine segment focuses solely on Regenerative Medicine technologies. The Company’s product portfolio and pipeline include EPIFIX, AMNIOFIX, mDHACM, AMNIOBURN, EPICORD and AMNIOCORD, AXIOFILL, and AMNIOEFFECT.
MiMedx Group Stock Price. Everything You Need To Know About The MiMedx Group Stock! performance
- Employees 867
- Company HQ Marietta
- Website https://mimedx.com/
- MDXG Asset Type Common Stock
- MDXG Market Capitalization 909.1M
- Earnings Per Share 0.43
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 4
MiMedx Group is a healthcare company that specializes in regenerative medicine therapies. With a focus on wound healing and tissue regeneration, MiMedx Group offers a unique investment opportunity for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Investing in MiMedx Group can provide investors with exposure to the growing field of regenerative medicine, which has the potential to revolutionize healthcare. To invest in MiMedx Group, retail investors from these countries can use the Zorion investment platform. Zorion provides investment insights and recommendations to help investors make informed decisions about their investments. With access to educational resources, investors can further enhance their knowledge and stay up to date with the latest developments in the regenerative medicine sector. Start investing in MiMedx Group with Zorion today and become a part of the future of healthcare.
